Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
Clinical trial NCT02483260 · SUSPENDED
Trial details
- NCT number
- NCT02483260
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- SUSPENDED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-16
- Primary completion
- 2027-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.